The Motley Fool
27 Jun 2026, 15:51 UTC · 2h ago
Trulieve CEO Sells $1.2 Million in Stock as Shares Jump 148% in One Year
NewsImpactScreener rates every claim in this story for market impact and maps it to the tickers most exposed.
The Motley Fool
27 Jun 2026, 15:51 UTC · 2h ago
NewsImpactScreener rates every claim in this story for market impact and maps it to the tickers most exposed.
What the story claims
3 claims · each scored for market impact
Trulieve became the first U.S. cannabis company approved to list on the New York Stock Exchange following the rescheduling of medical marijuana to Schedule III. — Listing on a major exchange significantly increases institutional accessibility, liquidity, and valuation potential for the stock.
+0.80Trulieve reported Q1 financials featuring $287 million in revenue, $100 million in adjusted EBITDA, and a positive net income of $2 million. — Positive net income and strong EBITDA demonstrate the company's ability to scale profitably in a challenging regulatory environment.
+0.50Chairman and CEO Kim Rivers sold 136,811 shares for approximately $1.2 million on June 26, 2026. — While insider selling can be a red flag, the relatively small amount compared to the company's size and the CEO's continued significant ownership mitigate the negative signal.
-0.20Which stocks this story touches
Continue reading
6 related stories
Search tags
The company shows strong financial momentum with positive net income, significant cash flow, and approval to list on the NYSE.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
How the impact breaks down
Where the story's weight lands
Stocks most exposed
Modeled from each name's sensitivity to this story
No stock impact ranking available yet.
The Motley Fool
1h ago
